BR9810285A - Solução, composição farmacêutica, e, cápsula de gelatina. - Google Patents

Solução, composição farmacêutica, e, cápsula de gelatina.

Info

Publication number
BR9810285A
BR9810285A BR9810285-0A BR9810285A BR9810285A BR 9810285 A BR9810285 A BR 9810285A BR 9810285 A BR9810285 A BR 9810285A BR 9810285 A BR9810285 A BR 9810285A
Authority
BR
Brazil
Prior art keywords
solution
pharmaceutical composition
present
gelatin capsule
invention describes
Prior art date
Application number
BR9810285-0A
Other languages
English (en)
Inventor
Alan Frank Parr
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR9810285A publication Critical patent/BR9810285A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SOLUçãO, COMPOSIçãO FARMACêUTICA, E, CáPSULA DE GELATINA". A presente invenção descreve uma nova solução compreendendo uma quantidade terapeuticamente efetiva de um azaesteróide farmaceuticamente ativo, poli(etileno-glicol) e propileno-glicol. Em outro aspecto, a presente invenção descreve uma composição farmacêutica compreendendo a solução da invenção. Em outro aspecto, a presente invenção descreve uma cápsula de gelatina cheia com a composição da presente invenção.
BR9810285-0A 1997-08-19 1998-08-17 Solução, composição farmacêutica, e, cápsula de gelatina. BR9810285A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717444.5A GB9717444D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition
PCT/EP1998/005192 WO1999008684A2 (en) 1997-08-19 1998-08-17 Solutions containing azasteroids

Publications (1)

Publication Number Publication Date
BR9810285A true BR9810285A (pt) 2000-09-12

Family

ID=10817633

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810285-0A BR9810285A (pt) 1997-08-19 1998-08-17 Solução, composição farmacêutica, e, cápsula de gelatina.

Country Status (10)

Country Link
EP (1) EP1005346A2 (pt)
JP (1) JP2002511100A (pt)
KR (1) KR20010014079A (pt)
CN (1) CN1263466A (pt)
AU (1) AU8979698A (pt)
BR (1) BR9810285A (pt)
CA (1) CA2295023A1 (pt)
GB (1) GB9717444D0 (pt)
TR (1) TR199903211T2 (pt)
WO (1) WO1999008684A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
EP1704162A1 (de) * 2004-01-02 2006-09-27 PharmaCon Forschung und Beratung GmbH Verfahren zur herstellung von 1,2-ungesätigten azasteroiden
EP2050436A1 (en) 2007-12-21 2009-04-22 Siegfried Generics International AG Pharmaceutical composition containing dutasteride
DE102008059201A1 (de) * 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
KR101055412B1 (ko) * 2010-11-19 2011-08-08 (주)비씨월드제약 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
MX369832B (es) * 2012-05-18 2019-11-22 Luoda Pharma Ltd Formulaciones líquidas que comprenden pimobendan y propilenglicol para el tratamiento de hipertensión y/o enfermedades cardiacas.
CN103479595B (zh) * 2012-06-13 2015-08-26 成都国弘医药有限公司 一种含有度他雄胺的软胶囊
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
CN103830201A (zh) * 2012-11-20 2014-06-04 重庆医药工业研究院有限责任公司 一种度他雄胺液体软胶囊
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
JP7017938B2 (ja) * 2018-01-15 2022-02-09 森下仁丹株式会社 ３－オキソ－４－アザアンドロスト－１－エン－１７－カルボン酸誘導体含有製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
WO1997011702A1 (en) * 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
WO1998025463A1 (en) * 1996-12-09 1998-06-18 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss

Also Published As

Publication number Publication date
CN1263466A (zh) 2000-08-16
GB9717444D0 (en) 1997-10-22
KR20010014079A (ko) 2001-02-26
CA2295023A1 (en) 1999-02-25
WO1999008684A3 (en) 1999-06-10
AU8979698A (en) 1999-03-08
JP2002511100A (ja) 2002-04-09
EP1005346A2 (en) 2000-06-07
TR199903211T2 (xx) 2000-04-21
WO1999008684A2 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
MY129356A (en) Electrospun pharmaceutical compositions
PT1028753E (pt) Libertacao de moleculas de poli(etilenoglicol)-conjugado a partir de hidrogeles degradaveis
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
CO4290295A1 (es) Medicamento en forma de comprimido con liberacion retardada de sustancia activa
TR199701169T1 (xx) Salmeterol i�in �l��lm�� doz inhaleri.
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
ID22878A (id) Komposisi aktif secara terapi
PT977565E (pt) Composicao farmaceutica compreendendo um composto triciclico com melhor estabilidade absorvibilidade e um potencial de irritacao reduzido
DE69110740T2 (de) Im Dickdarm zerfallende, Polypeptide enthaltende orale Formulierungen.
BR0007514A (pt) Macrolìdeos com atividade anti-inflamatória
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
BR9810458A (pt) Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida
FR2797185B1 (fr) Composition pharmaceutique flottante comprenant une phase active et une phase non active
NO980296L (no) Forbedrede terapeutiske midler
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DE59607949D1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired